Robert Perneczky

Professor Robert Perneczky serves as Chair in Translational Dementia Research at the University of Sheffield's School of Medicine and Population Health. Concurrently, he holds dual appointments as Professor and Head of the Division of Old Age Psychiatry at Ludwig-Maximilians-University Munich and as Principal Investigator at the German Center for Neurodegenerative Diseases (DZNE) Munich, maintaining active clinical and research roles across UK and German institutions since 2016.

Education

• MD and MBA
• Qualification at Technical University Munich, Germany (2001)

Research Interests

His work integrates Alzheimer's disease biomarker discovery (blood, CSF, RNA), advanced neuroimaging (MRI/PET), and neuroepidemiology to develop dementia prevention strategies. Key focuses include pharmacological/non-pharmacological interventions for dementia, frontotemporal dementia mechanisms, atypical Parkinson's disease diagnostics, and healthcare system preparedness for neurodegenerative conditions.

Scientific Awards

No scientific awards were mentioned in the provided text.

Advising and Grants

• AmyClear: Mechanisms of Amyloid Clearance in Alzheimer’s disease (VERUM Foundation/Sheffield BRC)
• ActiGliA: Cerebral Networks, Amyloid and Microglia in Aging (German Excellence Initiative/DZNE)
• Non-pharmacological dementia treatment (Robert-Vogel-Foundation)

He serves on the German memory clinics network executive board, Sheffield BRC executive board, and Neuroscience Flagship Institute executive board as Translational Neuroscience theme co-lead.

Laboratories and Teams

Based at Sheffield Institute for Translational Neuroscience (SITraN), he leads collaborative teams across SITraN and DZNE Munich, integrating clinical psychiatry with translational neuroscience to bridge laboratory findings and patient care in dementia treatment.